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Abstract 
The maternal nutritional state has long term metabolic consequences in offspring. We 
examined the relationship between different degrees of maternal overfeeding and adiposity 
on lipid and glucose homeostasis and central appetite regulators in offspring. F0 founders 
were fed chow (C) or high fat diet (HFD). F1 females from chow fed F0 were raised in 
normal (CN) or small (CS) litters (12 vs 3 pups/dam) and fed chow; a third group from HFD 
fed F0 was raised in normal litters and fed HFD (HN). Thus two degrees of overnutrition at 
F1 (CS, HN) were compared to control, CN. F2 pups were weaned onto chow (CNC, CSC, 
HNC) or HFD (CNH, CSH, HNH). At 21 weeks, CSC were heavier with 50% increased fat 
mass (vs CNC; P<0.01), while HNC and HNH offspring were heavier with 100% and 62% 
increases in fat mass (vs CNC and CNH; P<0.01). Both degrees of maternal overnutrition 
caused glucose intolerance in offspring consuming HFD. Maternal and postweaning HFD 
consumption was linked to increased leptin, insulin and triglycerides in offspring, with no 
maternal litter size effect. Hypothalamic signal transducer and activator of transcription-3 
(STAT-3) and suppressor of cytokine signaling-3 (SOCS-3) mRNA were significantly 
elevated in HNH (vs CNH; P<0.05). Skeletal muscle uncoupling protein3 (UCP-3) mRNA and 
adipose triglyceride lipase mRNA were downregulated only by postweaning HFD. Our data 
suggest that any level of F1 overnutrition increases adiposity in F2, with a greater impact of 
HFD induced maternal obesity. Additive effects were observed when F2 animals consumed 
HFD. 
 
Key words: maternal overnutrition, leptin, energy regulation, high fat diet, glucose 
homeostasis.  
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Abbreviations: 
AgRP   Agouti-gene-related protein 
ANOVA Analysis of Variance 
ATGL  Adipose triglyceride lipase  
BMI  Body mass index  
CART  Cocaine and amphetamine-regulated transcript  
CN  Chow normal litter 
CPT-1  Carnitine palmitoyltransferase-1  
CS  Chow small litter 
FA  Fatty acid  
HE  Hemotoxylin and eosin  
HFD  High fat diet  
HN  High fat diet normal litter 
HOMA Homeostatic model assessment 
IPGTT  Intraperitoneal glucose tolerance test  
NPY  Neuropeptide Y 
PCR  Polymerase Chain Reaction 
POMC  Pro-opiomelanocortin 
rRP  Right retroperitoneal 
SOCS-3 Suppressor of cytokine signaling-3  
SPSS  Statistical Package for Social Sciences 
STAT-3 Signal transducer and activator of transcription-3  
UCP-3  Uncoupling protein3  
UCPs  Uncoupling proteins  
WAT   White adipose tissue pads 
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Introduction   
Obesity has become a worldwide epidemic both in adults and in children. In many societies, 
maternal obesity is becoming the most common perturbation in pregnancy (Sebire et al., 
2001). This increases the likelihood of a cluster of disorders in offspring, including impaired 
glucose tolerance, insulin resistance, dyslipidemia, hypertension, and obesity (Boney et al., 
2005). Heavier mothers tend to have heavier babies and these babies go on to have a higher 
BMI in later life (Parsons et al., 2001). Obesity is also exacerbated by a variety of postnatal 
factors including lack of physical activity, unhealthy food choices, eg. calorie dense food 
(Serour et al., 2007; Mietus-Snyder & Lustig, 2008). As a result, a child’s current diet along 
with the prenatal environment, are critical determinants of the biochemical alterations that 
may predispose to metabolic disorders later in life.  
 
Food intake is regulated via a complex process comprising peripheral and central 
mechanisms. Animal studies indicate that maternal overnutrition exerts an important 
influence on the development of these appetite regulatory neural networks in offspring 
(Muhlhausler, 2007). The adipocyte-derived hormone leptin, a long term adiposity signal, 
acts centrally on Ob-Rb receptors predominantly in the hypothalamus (Tartaglia et al., 1995). 
It leads to phosphorylation of signal transduction and activator of transcription (STAT-3) to 
inhibit the expression of orexigenic neuropeptides, neuropeptide Y (NPY) and agouti-gene-
related protein (AgRP) while anorexigenic neuropeptides pro-opiomelanocortin (POMC) and 
cocaine and amphetamine-regulated transcript (CART) are stimulated to inhibit food intake 
(Schwartz et al., 2000), thus regulating body weight and fuel metabolism (Friedman & 
Halaas, 1998). However, high leptin levels are found in obese subjects, correlated with 
adipose tissue mass, which fail to bring about weight loss due to central leptin resistance 
(Scarpace & Zhang, 2009). This leptin resistance hypothesis was first suggested by Considine 
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et al. (1996) and in particular, SOCS-3 has been suggested as a potential mediator of central 
leptin resistance in obesity (Bjørbæk et al., 1998). Leptin has also been reported to increase 
sympathetic nerve activity resulting in hypertension (Mark et al., 1999).  
 
Skeletal muscle is thought to be a principal site for glucose metabolism and fatty acid (FA) 
oxidation thus contributing to insulin resistance (Petersen et al., 2007). Several factors may 
contribute to increased lipid deposition and insulin resistance. An increase in FA uptake may 
lead to cytosolic lipid accumulation that is associated with the development of insulin 
resistance (Hegarty et al., 2002). FA oxidation occurs in mitochondria through the process of 
β-oxidation and carnitine palmitoyltransferase-1 (CPT-1), a mitochondrial transmembrane 
enzyme, transports FA into mitochondria for β-oxidation and thus is a rate-limiting step in 
this process (McGarry & Brown, 1997). An increase in CPT-1 activity is sufficient to 
improve insulin resistance caused by high fat diet (HFD) (Bruce et al., 2009). Uncoupling 
proteins (UCPs), members of mitochondrial carrier family, uncouple oxidative metabolism 
from ATP synthesis, resulting in the production of heat instead of energy storage (Stuart et 
al., 1999). Adipose triglyceride lipase (ATGL) was recently cloned and known to hydrolyze 
triglycerides (TG) in adipose tissue (Jenkins et al., 2004). Loss of ATGL activity accumulates 
TG in several tissues (Haemmerle et al., 2006).    
 
The process by which prenatal and early postnatal environmental factors have long-term 
effects in adulthood is called programming and this is now considered a potential mechanism 
underlying the development of obesity, hyperphagia, cardiovascular and metabolic disorders 
later in life (Lucas, 1998; Armitage et al., 2004; McMillen & Robinson, 2005). The 
pathogenesis of programming is based on altered gene expression as a consequence of an 
adaptation to environmental changes (Breier et al., 2001). The plasticity of the hypothalamus 
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in late gestational age and early postnatal life (Grove & Smith, 2003) plays a key role in 
programming where adipose tissue secreted cytokines such as leptin are believed to act as key 
neurotrophic factors during brain development which may permanently influence appetite 
and metabolism (Bouret et al., 2004; Muhlhausler, 2007; Taylor & Poston, 2007; Cripps et 
al., 2009). The impact of maternal undernutrition on programming of obesity in offspring has 
been widely studied across species (Budge et al., 2004; Ozanne et al., 2004; Bispham et al., 
2005; Stocker et al., 2005); whereas relatively fewer studies have investigated the effect of 
maternal overnutrition (Armitage et al., 2005; Bayol et al., 2007; Samuelsson et al., 2008; 
Shankar et al., 2008), which is a more prominent health problem worldwide.  
 
Here we investigated the relationship between different degrees of maternal overnutrition and 
adiposity, hypothalamic appetite regulators, as well as glucose and lipid metabolism in the 
next generation. We generated two degrees of maternal overnutrition at F1, one group 
overfed during suckling and another rendered obese by postweaning HFD. To examine the 
impact of offspring’s current diet, half of the offspring from each mother group were exposed 
to HFD. Measurements on F2 offspring included food intake, blood pressure, glucose 
tolerance and plasma leptin, insulin and triglyceride levels. As our focus was the alteration in 
hypothalamic appetite regulators as well as glucose and lipid homeostasis, we also examined 
mRNA expression of hypothalamic appetite regulators (NPY, POMC, STAT-3, SOCS-3), 
CPT-1 and UCP-3 in muscle and ATGL in adipose tissue.  
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Materials and methods  
Animals and diet  
All animal experiments were approved by the Animal Experimentation Ethics Committee of 
the University of New South Wales. F0 female Sprague-Dawley rats were housed at 20 ± 2 
°C and maintained on a 12 h light and 12 h dark cycle. They were fed normal chow (14% fat 
by energy) or cafeteria HFD (34% fat by energy) for 6 weeks to produce two groups: Chow 
and HFD. At 13 weeks they were mated with chow fed male Sprague-Dawley rats. On day 1 
of life some F1 female pups from chow fed F0 mothers  were adjusted in normal litters (12 
pups per mother) and fed chow yielding chow normal litter (CN) while others were 
maintained in small litters (3 pups per mother) and fed chow to produce chow small litter 
(CS).  Female pups from HFD fed F0 mothers were maintained in normal litters (12 pups per 
mother) and after weaning they were offered HFD to produce HFD normal litter (HN). Thus 
at F1 two degrees of overnutrition had been achieved, by either early overfeeding during 
suckling (CS) or by offering HFD after weaning (HN). At 14 weeks of age these three groups 
CN, CS, HN were mated with chow fed males and were killed at approximately 22 weeks. 
After delivery the F2 litters were adjusted to 11 pups per mother and at weaning male rats 
were divided into two diets, HFD and chow which produced 6 groups of rats with different 
nutrition: CN-chow (CNC), CN-HFD (CNH), CS-chow (CSC), CS-HFD (CSH), HN-chow 
(HNC), HN-HFD (HNH) (Across all the treatments n = 12-17; Table 1). At the end point 
animals were killed at 21 weeks. 
 
Across all generations the chow diet groups were fed standard rodent chow (11 kJ/g, 14% fat, 
21% protein, 65% carbohydrates by energy) ad libitum and the HFD groups were presented 
daily with fresh and highly palatable, cafeteria-style high-fat foods  along with normal chow 
(15.33 kJ/g, 34% fat, 19% protein, 47% carbohydrates by energy), consisting of  meat pie, 
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dim sim, biscuits, cakes, pasta, chips and chow supplemented with condensed milk, milk 
powder and lard ad libitum.  
 
Body weight and energy intake measurement 
Body weights of F2 offspring were monitored every three days till weaning (20 days). F1 
mothers and postweaning F2 offspring were weighed weekly. Average 24 hour food intake 
(g) was calculated weekly from 5 to 15 weeks by carefully collecting and weighing the food 
remaining in the cage, subtracting this from the known amount given. The total energy (kJ) 
consumed by each group was calculated from the energy information supplied on the packet.  
 
Blood pressure measurement 
Blood pressure was measured at 12 weeks of age in conscious animals using tail-cuff pulse 
plethysmography (CODA-6, Kent Scientific Corporation, USA). Rats were pre-warmed by 
placing at 37 °C for 5 to 10 minutes to facilitate tail blood flow before blood pressure was 
measured. After 5 acclimation readings the average of 3-7 readings was used for each rat.  
 
Glucose tolerance test  
At 16 weeks an intraperitoneal glucose tolerance test (IPGTT) was performed on conscious 
animals after 6 hours fasting. A blood sample of 15µL was collected from the tail and 
baseline glucose was determined using a handheld glucometer (Accu-Chek Advantage 
Glucometer; Roche Diagnostics, NSW, AUS). The rats were then administered 2 g 
glucose/kg body weight (30% w/v) by intraperitoneal injection. Further blood samples were 
taken at 15, 30, 45, 60, 90 and 120 minutes for glucose determination. 
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Sample collection  
Blood samples (0.30 mL) were obtained from the tail vein of warmed conscious rats using a 
heparinised syringe (Pfizer, ON, USA; 1000 IU/mL saline) at 14 weeks of age to analyze the 
fasting glucose and insulin level. The insulin resistance index was estimated by homeostasis 
model assessment (HOMA): plasma insulin (ng/mL) × fasting plasma glucose 
(mmol/L)/(22.5 × 0.0417): the greater the HOMA value, the greater the level of  insulin 
resistance {Matthews, 1985 #271}{Schaalan,  #272} 
At day 20, when the pups were weaned into two diets, their mothers (F1) were deeply 
anesthetized with xylazine/ketamine (20/80 mg/kg). Body length (naso-anal) and girth 
(measured at base of ribcage) were taken before blood was removed by cardiac puncture. 
Then animals were decapitated to allow the rapid dissection and weighing of fat depots. At 
the endpoint (21 weeks), non-fasted adult F2 rats were killed by decapitation and the brain 
was placed ventral side up. Coronal cuts were made at the optic chiasm and the rostral border 
of the hypothalamus. The hypothalamus (minus preoptic area) was separated by making 
incisions at the lateral edges of the hypothalamic sulcus and above the third ventricle. The 
ventral hypothalamus  containing the arcuate nucleus (ARC) was snap frozen.  White adipose 
tissue (WAT: rRP, right retroperitoneal, gonadal and mesenteric), left kidney, heart, muscle 
and liver were collected and weighed.  Hypothalamus, soleus muscle and rRP WAT were 
snap frozen in liquid nitrogen and then stored at -80 °C for later measurement of mRNA 
expression. Tibia length was recorded. Body mass index (BMI) was calculated as kg/m2. A 
section of liver was fixed in 4% formaldehyde for hemotoxylin and eosin (HE) staining. 
 
Plasma biochemistry 
Glucose was measured (Accu-Check Advantage Glucometer; Roche Diagnostics, NSW, 
AUS) before the blood was centrifuged at 10,000 rpm for 8 minutes (Eppendorf Minispin; 
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Crown Scientific, NSW, AUS). Separated plasma was stored at -20 °C. Plasma leptin and 
insulin concentrations were analyzed using commercially available radioimmunoassay kits 
according to manufacturer’s instructions (Linco, MO, USA). Plasma TG was analyzed 
colorimetrically (490 nm; Bio-Rad 680XR, NSW, AUS) using a commercially available 
triglyceride reagent (Roche, NSW, AUS) and standard (Sigma, VIC, AUS). 
 
HE staining of liver 
A section of the middle liver lobe from each rat was placed in 4% formaldehyde overnight, 
then transferred to 70% ethanol till embedded in paraffin wax. Mounted tissues were then 
deparaffinized and rehydrated. Nuclei were stained with hematoxylin and cell cytoplasm was 
stained with eosin. Fatty change in liver was graded by an observer blinded to the treatment 
groups by assessing the amount and size of white vacuoles present throughout the stained 
section (0 = No fat vacuoles, 1 = few small lipid vacuoles, 2 = increased number of small fat 
vacuoles and some big vacuoles, 3 = hepatocytes filled by big fat vacuoles). The average of 
the grades within each treatment group was then calculated. 
 
Real – time PCR: 
Quantitative real time polymerase chain reaction (PCR) was used to determine mRNA 
expression of NPY, POMC, SOCS-3, STAT-3, and leptin receptor (Ob-Rb) in ventral 
hypothalamus, CPT-1 and UCP-3 in soleus and ATGL in rRP WAT. Total RNA was 
extracted by homogenizing tissue with Tri reagent (SIGMA, Missouri, USA), separated by 
chloroform, precipitated with isopropyl alcohol and then washed with 75% ethanol. The 
purified total RNA was used as a template to generate first-strand cDNA using M-MLV 
Reverse Transcriptase, RNase H Minus, Point Mutant Kit, (Promega Corporation, WI, USA). 
Pre-optimized probe/primers (Applied biosystem) were used for quantitative PCR (Realplex 
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software). Ob-Rb, STAT-3, SOCS-3, NPY and POMC mRNA levels in hypothalamus and 
UCP3 in muscle were compared to housekeeping gene ribosomal 18s RNA. ATGL mRNA 
levels in rRP were compared to housekeeping gene beta actin. The housekeeping gene was 
labeled by VIC and target gene by FAM where our gene of interest was standardized to 
control. An individual sample from the control CN-chow group was then arbitrarily assigned 
as a calibrator against which all other samples are expressed as fold difference.  
 
Statistics 
Results are expressed as mean ± SEM. Maternal characteristics and pre-weaning data were 
analyzed by one way ANOVA followed by least significant difference using SPSS (version 
15). Post weaning weekly body weights and blood glucose concentrations in IPGTT were 
analyzed by one-way ANOVA with repeated measures, followed by LSD. Food intake, blood 
pressure and endpoint organ weights, body weight, fat masses, plasma markers, mRNA levels 
were analyzed by two-way ANOVA followed by least significant difference test using SPSS. 
If two-way ANOVA showed significant overall maternal effects, then it was followed by one 
way ANOVA to look at maternal effects separately in chow and HFD groups. Correlation 
between the body weight and fat masses was assessed by Pearson’s correlation. 
 
Results   
Maternal characteristics (F1) 
Consumption of HFD led to marked increases in body weight in F1 females with modest 
effects of litter size adjustment (Fig 1). At 22 weeks HN rats were 17% heavier than CN rats, 
with a marked increase in sampled WATS (P < 0.001) and a doubling of plasma leptin and 
triglyceride concentrations (P < 0.01 and 0.05 respectively; Table 2). Although CS F1 
females were 6% heavier than CN rats, one way ANOVA showed no overall effect of litter 
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size (CS vs CN) on body weight, fat masses, plasma leptin and TG. Plasma insulin remained 
unchanged by HFD feeding and litter size adjustment (HN, CS vs CN; P > 0.05; Table 2).   
 
Effects of maternal (F1) overnutrition and postweaning HFD (F2) on F2 offspring 
Preweaning 
During early development F2 offspring maintained the body weight pattern of their mothers 
(Fig 2A). By 4 days the offspring of HN dams (11.04 ± 0.18) were significantly heavier than 
those of CN dams (10.34 ± 0.17g; P < 0.01). After 7 days both HN (17.48 ± 0.28) and CS 
(15.45 ± 0.28g) offspring were significantly heavier than CN offspring (14.61 ± 0.26g; P < 
0.05). At 19 days of age, maternal HFD had caused a 36% increase (HN vs CN offspring, 
46.74 ± 0.51 vs 34.23 ± 0.47g; P < 0.001) and maternal litter size a 7% increase (CS  
offspring 36.89 ± 0.70g; P <  0.01) in body weight over CN offspring (Fig 2A). 
 
Postweaning  
Body weight. Overnutrition of F1 mothers due to both HFD related maternal obesity and 
reduced litter size led to significantly greater body weights in postweaning F2 offspring. 
Maternal HFD effects were significant from 5 weeks (P < 0.001; Fig 2B) and maternal litter 
size effects from 9 weeks (P < 0.05; Fig 2B). This pattern was observed in both diet groups, 
with the greatest impact in offspring of HN mothers consuming HFD. At 20 weeks the 
maternal litter size effect on body weight was abolished (Fig 2B). At the end of the study (21 
weeks), body weight of F2 offspring of HN and CS dams were 16% and 11% greater than 
that of CN dams consuming chow (HNC vs CNC, CSC vs CNC; P < 0.001, < 0.01 respectively; 
Table 3). In HFD animals, the impact of maternal liter size was not evident; while offspring 
from HN dams were 19% heavier than CN offspring (HNH vs CNH; P < 0.01; Table 3). No 
significant difference was observed in body length (data not shown) while BMI was 
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significantly increased by both degrees of maternal overnutrition across both diet groups 
(HNc, CSC vs CNC; HNH, CNH vs CNH; P < 0.001; Table 3). As expected, postweaning HFD 
led to significant increases in body weight from 8 weeks across all maternal groups (P < 
0.001; Fig 2B) and continued till the end point. At that time consumption of postweaning 
HFD also led to increases in BMI across all mother groups (HFD vs chow offspring; P < 
0.001; Table 3).  
 
Glucose homeostasis. During the 16 week IPGTT, baseline glucose levels were not affected 
by maternal groups. However glucose concentrations were increased by both degrees of 
maternal overnutrition at 30 minutes in HFD fed groups (HNH, CSH vs CNH; P < 0.05, 0.01 
respectively; Fig 3A). Only maternal HFD effect continued at 45, 60 and 90 minutes (HNH vs 
CNH; P < 0.01). Current HFD effect was observed in offspring of CN dams at 15 and 30 
minutes (CNH vs CNC), in CS offspring from 0 to 60 minutes (CSH vs CSC) and in HN 
offspring from 30 to 120 minutes (HNH vs HNC; Fig 3A).  
 
The area under the glucose tolerance test is shown in Fig 3B. No significant maternal effect 
was observed in animals consuming chow, however when rats consumed HFD, AUC was 
increased in offspring by both degrees of maternal overnutrition (HNH, CSH vs CNH; P < 
0.05). AUC were also higher in rats currently consuming HFD across all mother groups (P < 
0.001).  
 
At 14 weeks insulin concentration (Fig 3C) and HOMA (Fig 3D) were significantly higher in 
the offspring of HN dams relative to those of CN dams in both diet groups (HNH vs CNH; P < 
0.001 for all). No significant maternal litter size effect was observed on fasting plasma insulin 
and HOMA (CS vs CN offspring, both diet groups). Consumption of HFD postweaning 
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caused significant increases in insulin concentration and HOMA in F2 offspring (HFD vs 
chow fed offspring; P < 0.001, Fig 3B, 3C, 3D). 
 
Adiposity. In line with the increased body weight, in both diet groups a significant maternal 
HFD effect was observed on offspring rRP, gonadal and mesenteric WAT (P < 0.001, Table 
3). A similar pattern is apparent in total sampled fat mass expressed as net weight or percent 
body weight (HNc vs CNC, HNH vs CNH; P < 0.001, Fig 4A, 4B). A significant maternal litter 
size effect on WAT was only observed in the chow fed offspring (CSC vs CNC P < 0.01; Fig 
4A, 4B; Table 3). When both diet groups were combined, there was a significant positive 
correlation between body weight and % total fat in offspring across all mother groups (CN 
offspring r = 0.833, P < 0.001; CS offspring r = 0.882, P < 0.001; HN offspring r = 0.870, P 
< 0.001). Postweaning HFD consumption in F2 offspring led to significant increases in fat 
masses both when expressed as net or percent body weight (HFD vs chow fed offspring; P < 
0.001; Fig 4A, 4B; Table 3).  
 
Leptin was increased in offspring of HN dams compared to CN offspring in both diet groups 
(HNc vs CNC, HNH vs CNH; Fig 4C; P < 0.001). No significant effect of maternal litter size 
was observed. As expected offspring postweaning HFD led to marked increases in leptin (P < 
0.001; Fig 4C). Leptin concentration and percent total fat showed a highly positive 
correlation (r = 0.853, P < 0.001) when offspring from the three mother groups and both diets 
were combined.  
 
Lipid regulators. Significant effects of maternal HFD (HNc vs CNC, HNH vs CNH; P < 0.001) 
and offspring postweaning HFD (HFD vs chow fed offspring across all mother groups; P < 
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0.01) were observed on plasma TG (Fig 4D). No effect of maternal litter size was observed 
on plasma TG (CS vs CN offspring; Fig 4D). 
 
In rRP WAT, mRNA expression of lipase ATGL were significantly decreased by 
postweaning HFD in offspring across all mother groups (HFD vs chow fed offspring; P < 
0.05, Fig 5A). In skeletal muscle there was also overall postweaning HFD effect in UCP-3 
mRNA expression (HFD vs chow fed offspring; P < 0.05, Fig 5B). UCP-3 expression was 
increased in offspring of HN dams fed HFD (HNH vs CNH; P < 0.05; Fig 5B). We did not see 
any significant result in CPT-1 expression (data not shown). 
 
Systolic blood pressure. Within each diet group, no significant maternal effect was observed 
on systolic blood pressure, diastolic blood pressure and heart rate (Table 3). Obesity induced 
by consumption of HFD in F2 offspring was associated with significant increases in systolic 
and diastolic pressures (HFD vs chow fed offspring; P < 0.01; Table 3).  
 
Food intake and central appetite regulators. The total kJ consumed by the offspring of HN 
dams from 5 to 15 weeks was 11% higher than that of offspring of CN dams in both chow 
and HFD groups (HNc vs CNC, HNH vs CNH; P < 0.05, 0.01 respectively; Table 3). A similar 
pattern was observed when gram of food consumed was examined (data not shown). 
However, when total kJ was adjusted by body weight, no significant effect on food intake 
was observed in HN offspring. CS offspring ate similar amounts to those of CN mothers. 
Across all maternal groups, consumption of HFD led to a doubling of kJ intake compared to 
chow fed offspring (P < 0.001; Table 3). 
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Hypothalamic Ob-Rb mRNA expression was significantly increased in the offspring of HN 
dams compared to CN offspring consuming HFD (HNH vs CNH; P < 0.01; Fig 6A). Within 
the chow diet group CS offspring showed a significant decrease in Ob-Rb mRNA expression 
compared to CN offspring (CSc vs CNc; P < 0.05; Fig 6A). STAT-3 mRNA expression 
showed a similar pattern to that of Ob-Rb (Fig 6B). The analysis also showed significant 
increase in SOCS-3 mRNA expression in offspring of HN dams consuming HFD, compared 
to CN offspring (HNH vs CNH; P < 0.05) P <0.05; Fig 6C). Postweaning HFD also caused an 
overall increase in SOCS-3 expression (HFD vs chow offspring, P <0.01; Fig 6C). No 
significant differences were observed in hypothalamic NPY and POMC mRNA expression 
(6D, 6E). 
 
 
Discussion  
A number of animal studies indicate that obesity may have a “programmed origin” (Lucas, 
1998; Armitage et al., 2005; Muhlhausler, 2007; Taylor & Poston, 2007). The current study 
shows that any degree of maternal obesity, either maternal obesity due to HFD feeding prior 
to and during pregnancy or early postnatal overnutrition of the mother due to small litter size, 
increased adiposity and glucose intolerance in F2 offspring. Overall, maternal obesity exerted 
greater effects on offspring adiposity, and glucose and lipid homeostasis than maternal early 
postnatal overfeeding. The current diet also had an important impact. While effects of 
maternal early overnutrition were only evident in offspring consuming chow, those of 
maternal obesity appeared to be amplified when offspring consumed HFD. 
 
Maternal HFD consumption during pregnancy and lactation is an important contributing 
factor to the development of obesity in adulthood (Bayol et al., 2007). An enriched milk 
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content of obese mothers (Gorski et al., 2006) as well as increased quantity of milk consumed 
by pups of obese mothers (Chen et al., 2008), may have contributed to their obesity. As a 
result, in our study offspring from HN dams showed significant increases in body weight gain 
during development and at the endpoint they were heavier with elevated BMI in both diet 
groups. In this study overnutrition imposed by reduced competition for milk during suckling 
did not result in marked changes in adiposity or body weight in mothers. Insulin was 
increased albeit non significantly. Previous work from this and other laboratories showed 
litter size reduction resulted in time-dependent increases in body weight, fat mass and fat cell 
number (Bassett & Craig, 1988; Velkoska et al., 2005). This may be related to the duration of 
the intervention, as previously, significant effects of litter size adjustment were observed 
early in life (up to 10 weeks) and abated over time (Velkoska et al., 2005).  Further, our 
number of animals (6-7) may have influenced our capacity to observe significant effects. To 
our knowledge, this is the first study documenting an impact of maternal overnutrition 
induced by litter size adjustment on the next generation. A late onset impact on body weight 
was observed in offspring from CS dams, which were heavier than those from CN from 9 
weeks of age. At 21 weeks, chow fed offspring from CS dams showed significant increases in 
body weight compared to offspring of CN mothers, but this effect was absent in rats 
consuming HFD.  This suggests that the effect of postweaning HFD is so strong that it can 
override the impact of maternal early-life overnutrition on offspring.  
 
In our study maternal obesity induced by HFD caused hyperleptinemia in offspring, which 
would be predicted for their increased fat content, in line with other studies (Parente et al., 
2008; Samuelsson et al., 2008). Earlier reports of overnutrition due to litter size adjustment 
showed a time dependent elevation in plasma leptin at 8 weeks, but by 16 weeks it 
disappeared (Morris et al., 2005). In this study there was no significant litter size effect on 
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plasma leptin concentration in the F1 mother, so it is perhaps not surprising that leptin was 
normal in her offspring. The time points chosen may limit our ability to see any significant 
changes in plasma leptin concentration. However CS offspring showed increased fat mass 
only in the chow group, suggesting maternal overfeeding due to small litter size may still play 
a small but important role in the offspring.  
 
In agreement with other studies examining adult offspring maternal HFD consumption led to 
hyperinsulinemia with significantly higher HOMA in offspring, suggesting maternal obesity 
is strongly linked to insulin resistance in offspring (Samuelsson et al., 2008; Nivoit et al., 
2009). Postweaning HFD also resulted in a greater HOMA value, indicating insulin resistance. 
Maternal litter size did not have any effect on HOMA, however it impaired glucose handling 
during IPGTT. The offspring of small litter dams showed delayed glucose clearance at 15 and 
30 min, with more prolonged effects in HFD fed rats from HN dams. Higher glucose levels 
resulting from lower glucose utilization in peripheral tissues is a typical feature in obesity. 
Increased area under the IPGTT curve was seen in offspring from both degrees of maternal 
overnutrition, but this was only unmasked when offspring consumed HFD, suggesting an 
interaction between maternal phenotype and current diet increased the risk of glucose 
intolerance.  
 
Maternal obesity due to a fat rich diet during pregnancy and lactation (Chang et al., 2008) as 
well as a lifetime of HFD consumption (Howie et al., 2009) might reflect a 
“malprogramming” of hypothalamic neuropeptidergic systems possibly related to defective 
leptin signaling in the hypothalamus, leading to permanently altered appetite regulatory 
functions in offspring. Maternal junk food during gestation and lactation may lead pups to 
develop an exacerbated preference for fatty, sugary and salty foods (Bayol et al., 2007). In 
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this study central Ob-Rb was upregulated by maternal obesity in offspring consuming HFD. 
Changes in its downstream mediator STAT-3 mRNA expression mirrored those in Ob-Rb 
receptor. But the simultaneous upregulation of the suppressor of cytokine signaling SOCS-3 
suggests central leptin resistance (Bjørbæk et al., 1998). Although cafeteria diet and leptin are 
known to modulate the hypothalamic appetite regulators NPY and POMC (Korner et al., 
1999; Hansen et al., 2004), central leptin resistance due to upregulated SOCS-3, may help to 
explain why in our study no significant changes in hypothalamic NPY and POMC expression 
were observed in response to elevated leptin induced by maternal HFD. Hyperphagia would 
be consistent with SOCS-3 overexpression by maternal HFD, and offspring of HN dams 
tended to eat more than the other groups, especially when consuming HFD. This suggests that 
the altered hypothalamic neuronal changes due to maternal obesity led to transmission of 
increased susceptibility to hyperphagia and obesity in offspring. Upregulation of SOCS-3 was 
also found with prolonged postweaning HFD, may contribute to central leptin resistance and 
thus alter normal control of food intake. Although maternal litter size caused downstream 
regulation of Ob-Rb and STAT-3 in chow fed offspring, they appeared to consume slightly 
more kJ, which was entirely accounted for their heavier body weight. Thus, different degrees 
of maternal obesity at F1 can alter offspring appetite control differently.  
 
Postweaning HFD caused increased fat mass with elevated leptin and downregulation of 
UCP-3 in muscle and ATGL in rRP WAT. It has been suggested that UCP-3 acts as a FA 
anion exporter, protecting mitochondria against peroxidation and allowing continued rapid 
FA oxidation (Echtay, 2007). However the role of UCP-3 in energy expenditure is 
controversial. Some studies showed significantly elevated UCP-3 in HFD animals (Chou et 
al., 2001; Turner et al., 2007) while there was also evidence of downregulation of UCP-3 by 
high fat feeding (Corbalan et al., 1999). The fasting state can also cause the upregulation of 
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UCP-3 to oxidize FA as energy supply (Boss et al., 1998; Weigle et al., 1998). In our study 
the animals were not fasted and downregulation of UCP-3 expression across all mother 
groups may be linked to reduced capacity of FA oxidation leading to the accumulation of TG. 
On the other hand, fat ATGL mRNA expression, which has strong negative correlations with 
obesity and insulin resistance (Jocken et al., 2007), was also downregulated in insulin 
resistant HFD-fed offspring across all maternal groups in our study, suggesting a slower rate 
of lipolysis in HFD rats. Concomitant increases in plasma TG and body fat mass may be due 
to this reduced lipolysis, behind which ATGL and UCP-3 plays a vital role. 
 
Other studies in mice showed increased blood pressure in offspring from obese mothers 
(Samuelsson et al., 2008); however this was not observed in this study possibly due to 
differences in methodology. Postweaning HFD caused an elevation in systolic and diastolic 
blood pressure. Hyperleptinemia and hyperinsulinemia have both been linked to sympathetic 
activation associated with obesity related hypertension (Rahmouni et al., 2005; Ferrannini, 
2006).  This may explain our finding of an overall HFD effect on blood pressure with 
increased leptin and insulin across all mother groups. The HFD rats were also hyperphagic 
with leptin resistance related to SOCS-3 overexpression. Selective leptin resistance may 
contribute to the inability of leptin to activate downstream signaling pathways in the arcuate 
nucleus but preservation of leptin action in other cardiovascular related hypothalamic areas 
(Rahmouni et al., 2005). Further investigation is needed to examine the cardiovascular 
consequences of maternal overnutrition and postweaning HFD. 
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Conclusion 
Our data indicate that any level of maternal overnutrition increases offspring adiposity at 
adulthood, with a greater impact of HFD induced maternal obesity than early overfeeding due 
to litter size reduction. Thus offspring from HFD-fed mothers were at the highest risk of a 
cluster of disorders including impaired glucose tolerance, insulin resistance, dyslipidemia, 
and obesity.  Additive effects were observed with offspring's own HFD. Modest maternal 
overweight due to early life overnutrition influenced offspring body weight more in those 
consuming a low fat diet post weaning. Further study is required to investigate the reason for 
the elevation of blood pressure induced by HFD across all mother groups. 
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Figure legends  
Fig 1 Mother’s (F1) body weight in rats raised in normal sized litters (CN) or small sized 
litters (CS) and consuming chow or raised in normal sized litters and consuming HFD (HN). 
Results are expressed as mean ± SEM (n = 6-7).  
††, ††† HFD effect P < 0.01, 0.001 (HN vs CN). 
 
Fig 2 F2 offspring body weight from day 1 to day 19 (A) and postweaning from 5 to 20 
weeks (B) from CN (circle), CS (triangle) and HN (square) mothers. Results are expressed as 
mean ± SEM; n = 34-44 (A) or n = 10-11 (B). In panel B, solid symbols represent mothers ID 
and the subscript refer to the offspring’s current diet (C, chow; H, HFD).  
††, ††† Maternal (F1) HFD effect P < 0.01, 0.001 (HN vs CN offspring) 
#, ## Maternal litter size (F1) effect P < 0.05, 0.01 (CS vs CN offspring)  
*** Current (F2) HFD effect P < 0.001 (HFD vs chow fed offspring across all mother 
groups). 
 
Fig 3 (A) Blood glucose concentrations during GTT in offspring from CN mother fed chow 
(○), CN mother fed HFD (●), CS mother fed chow (∆), CS mother fed HFD (▲), HN mother 
fed Chow (□), HN mother fed HFD (■). (B) AUC of GTT (C) Fasting insulin concentrations 
(D) HOMA of CN-offspring fed chow (CNC) and HFD (CNH), CS-offspring fed chow (CSC) 
and HFD (CSH) and HN-offspring fed chow (HNC) and HFD (HNH). Results are expressed as 
mean ± SEM (n = 8-12).  
†, ††† Maternal (F1) HFD effect P < 0.05, 0.001 (HNC vs CNC / HNH vs CNH) 
# Maternal (F1) litter size effect P < 0.05 (CSH vs CNH) 
*** Current (F2) HFD effect P < 0.001 (HFD vs chow fed offspring across all mother 
groups).  
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Fig 4 Total WAT sampled expressed as g (A) and (B) percent body weight. (C) plasma leptin 
and (D) triglycerides at 21 weeks in F2 offspring of CN mother fed chow (CNC) and HFD 
(CNH), CS mother fed chow (CSC) and HFD (CSH) and HN mother fed chow (HNC) and HFD 
(HNH). Results are expressed as mean ± SEM (n = 12-17).  
††† Maternal HFD effect P < 0.001 (HNC vs CNC / HNH vs CNH) 
## Maternal litter size effect P < 0.01 (CSC vs CNC) 
**, *** Current HFD effect P < 0.01, 0.001 (HFD vs chow fed offspring across all mother 
groups).  
 
Fig 5 Lipid regulators (A) Adipose triglyceride lipase (ATGL) in retroperitoneal WAT (rRP) 
(B) Uncoupling proteins (UCP-3) in skeletal muscle at 21 weeks in F2 offspring of CN 
mother fed chow (CNC) and HFD (CNH), CS mother fed chow (CSC) and HFD (CSH) and HN 
mother fed chow (HNC) and HFD (HNH). Results are expressed as mean ± SEM (n = 6-8). 
† Maternal HFD effect P < 0.05 (HNH vs CNH) 
* Current HFD effect P < 0.05 (HFD vs chow fed offspring across all mother groups).  
 
Fig 6 mRNA expression of (A) Ob-Rb receptor (B) signal transducer and activator of 
transcription, STAT-3 (C) suppressor of cytokine signaling, SOCS-3 (D) Pro-
opiomelanocortin, POMC (E) Neuropeptide Y, NPY in ventral hypothalamus at 21 weeks in 
F2 offspring of CN mother fed chow (CNC) and HFD (CNH), CS mother fed chow (CSC) and 
HFD (CSH) and HN mother fed chow (HNC) and HFD (HNH). Results are expressed as mean 
± SEM (n = 8).  
†, †† Maternal HFD effect P < 0.05, 0.01 (HNH vs CNH) 
# Maternal litter size effect P < 0.05 (CSC vs CNC) 
** Current HFD effect P < 0.01 (HFD vs chow fed offspring across all mother groups).  
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Table legends  
 
 
Table 1. Experimental procedure. 
 
 
Table 2. Maternal (F1) characteristics  
 
 
Table 3. Body weight, fat mass, food intake, liver fatty changes and blood pressure in F2 rat. 
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Table 1. Experimental Procedure    
F0 (Diet) F1 (Intervention) F2 (diet) F2 ID 
 Chow normal litter (CN); n = 7 Chow CN-chow (CNC); n = 17 
Chow  HFD CN-HFD  (CNH); n = 14 
 Chow small litter (CS); n = 6 Chow CS-chow (CSC); n = 12 
  HFD CS-HFD  (CSH); n = 12 
HFD HFD normal litter (HN); n = 7 Chow HN-chow (HNC); n = 17 
  HFD HN-HFD  (HNH); n = 15 
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Table 2. Maternal (F1) characteristics  
Mothers CN (n = 7) CS (n = 6) HN (n =7) 
BW at kill (22 wks) 327.2  ± 14.5 345.6  ± 16.0 382.1  ± 8.0†† 
rRP (% BW) 0.24  ± 0.05 0.29  ± 0.05 1.93  ± 0.56†† 
Gonadal (% BW) 0.48  ± 0.08 0.65  ± 0.06 1.96  ± 0.19††† 
Mesenteric (% BW) 0.40  ± 0.06 0.50  ± 0.04 1.45  ± 0.18††† 
Total (% BW) 1.25  ± 0.19 1.64  ± 0.11 5.95  ± 0.44††† 
Leptin (ng/mL)                1.59  ± 0.24 1.52  ± 0.11 3.23  ± 0.16††† 
Insulin (ng/mL) 0.20 ± 0.03 0.44  ± 0.14 0.28  ± 0.07 
Triglycerides (mmol/L) 0.16  ± 0.03 0.17  ± 0.02 0.28  ± 0.04† 
 
Values expressed as mean ± SEM. †, ††, ††† HFD effect P < 0.05, 0.01, 0.001 (HN vs CN) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 32 
Table 3. Body weight, fat mass, food intake, liver fatty changes and blood pressure in F2 rat. 
 
 Chow HFD Effects (P values) 
 CN offspring CS offspring HN offspring CN offspring CS offspring HN offspring Mother's litter size Mother's HFD 
Overall current 
diet 
 (n = 17) (n = 12) (n = 16) (n = 14) (n = 14) (n = 15) 
CSCvsCNC/ 
CSHvsCNH 
HNCvsCNC/ 
HNHvsCNH 
HFD vs chow 
offspring 
BW at 21 weeks (g) 454.9  ± 20.9 504.7  ± 14.3 528.8   ± 11.6 607.1  ± 8.9 627.5   ± 8.5 723.1   ± 17.0 <0.01 / NS <0.001 / <0.001 <0.001 
BMI (Kg/M2)  6.85  ± 0.19 7.59  ± 0.28 7.93   ± 0.15 8.57   ± 0.15 9.21   ± 0.35 9.70  ± 0.21 <0.001 / 0.001 <0.001 / <0.001 <0.001 
rRP WAT (g) 2.46   ± 0.21 3.95  ± 0.44 5.20   ± 0.32 12.47  ± 0.80 12.74   ± 0.87 22.77  ± 1.14 <0.01 / NS <0.001 / <0.001 <0.001 
Gonadal WAT (g) 5.14   ± 0.23 6.90  ± 0.70 8.87   ± 0.55 17.56   ± 1.08 19.49   ± 1.33 26.50   ± 1.41 <0.05 / NS <0.001 / <0.001 <0.001 
Mesenteric WAT (g) 3.49  ± 0.23 4.75  ± 0.48 5.93  ± 0.42 10.13   ± 0.49 11.98   ± 0.71 16.44   ± 1.21 <0.05 / NS <0.001 / <0.001 <0.001 
Liver (g)    12.9  ± 0.6 14.2  ± 0.7 14.4   ± 0.6 17.4   ± 0.9 17.2   ± 1.4 19.0   ± 0.7 NS / NS <0.05 / NS <0.001 
rRP WAT (%BW) 0.54  ± 0.03 0.78  ± 0.07 0.98   ± 0.05 2.05   ± 0.13 2.02   ± 0.12 3.11  ± 0.13 <0.01 / NS <0.001 / <0.001 <0.001 
Gonadal WAT (%BW) 1.13  ± 0.05 1.35  ± 0.09 1.67   ± 0.08 2.88   ± 0.18 3.09  ± 0.17 3.64   ± 0.18 <0.05 / NS <0.001 / <0.001 <0.001 
Mesenteric WAT(%BW) 0.78  ± 0.04 0.86  ± 0.11 1.11    ± 0.06 1.66   ± 0.08 1.89   ± 0.09 2.23   ± 0.15 NS / NS <0.001 / <0.001 <0.001 
Liver (%BW) 2.85   ± 0.12 2.82  ± 0.09 2.72   ± 0.06 2.85   ± 0.15 2.73   ± 0.23 2.61   ± 0.07 NS / NS NS / NS NS 
Food intake (kJ/rat)*103 25.2   ± 0.6 25.9  ± 0.8 28.0   ± 0.4 48.6   ± 0.3 51.7  ± 2.2 54.3   ± 0.9 NS / NS <0.05 / <0.01 <0.001 
Liver fatty changes 0.26 ± 0.12 0.33 ± 0.11 0.33 ± 0.06 1.30 ± 0.13 2.07 ± 0.21 1.92 ± 0.08 NS / <0.05 NS / <0.01 <0.001 
Systolic BP (mmHg)  129.5   ± 4.4 125.6  ± 3.7 130.5   ± 5.5 143.9   ± 1.7 139.2   ± 7.4 151.9   ± 2.9 NS / NS NS / NS <0.001 
Diastolic BP (mmHg)    84.4  ± 2.1 81.1  ± 2.8 83.5   ± 3.9 97.9   ± 1.7 91.3   ± 6.8 96.7  ± 2.9 NS / NS NS / NS <0.001 
Heart rate (beats/min) 394.2   ± 12.2 403.6  ± 15.7 473.5   ± 18.4 428.4   ± 13.0 433.6   ± 25.6 377.0   ± 15.5 NS / NS NS / NS NS 
 
Abbreviations: BW, body weight; BMI, body mass index; WAT, white adipose tissue; rRP, retroperitoneal.  Time points: body weight, fat and organ weights in gram and % body weight at kill (21 
weeks), food intake (5-15 weeks), Blood pressure (12 weeks). Values expressed as mean ± SEM.   
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Fig 4 
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Fig 5 
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Fig 6 
 
